Brain Immune Cells Shift at Age 50, NIH Study Finds
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- NIH-funded researchers found that microglia in the hippocampus begin declining around age 50, with the loss continuing through approximately age 75 as more inflammatory cells take their place
- The study analyzed postmortem hippocampal tissue from 40 neurologically healthy adults aged 20 to 95 using advanced single-cell methods, combining gene expression with 3D genome mapping and epigenetic profiling
- The discovery challenges the long-standing assumption that microglia — which first develop during embryonic growth — self-renew in place throughout life without being replaced
- Replacement immune cells showed stronger inflammatory signals and traits similar to immune cells originating in peripheral blood rather than resident brain tissue
- The research team found blood-brain barrier cells also showed age-related decline, with widespread coordinated changes in genome structure across multiple brain cell types
- The findings were published in Science, with researchers planning follow-up work to test whether the immune cell transition directly contributes to Alzheimer's and other neurodegenerative diseases
Why it matters: Aging is the single largest risk factor for dementia, and this study pinpoints a specific midlife cellular transition — loss of resident microglia and replacement by inflammatory blood-derived cells — that may explain the chronic brain inflammation underlying Alzheimer's, potentially opening intervention targets decades before symptoms typically appear.
